Willow Biosciences (WLLW) Insider Trading & Ownership C$0.10 +0.01 (+11.76%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider Trades Willow Biosciences (TSE:WLLW) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.34%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$7,957.50Number OfInsiders Selling(Last 12 Months)0 Get WLLW Insider Trade Alerts Want to know when executives and insiders are buying or selling Willow Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address WLLW Insider Buying and Selling by Quarter Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Willow Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2024Travis DoupeSenior OfficerBuy49,500C$0.09C$4,207.5011/29/2023Christopher Kenneth SavileDirectorBuy50,000C$0.08C$3,750.00 (Data available from 1/1/2013 forward) WLLW Insider Trading Activity - Frequently Asked Questions Who is on Willow Biosciences's Insider Roster? The list of insiders at Willow Biosciences includes Christopher Kenneth Savile, Peter Seufer-Wasserthal, and Travis Doupe. Learn more on insiders at WLLW. What percentage of Willow Biosciences stock is owned by insiders? 24.34% of Willow Biosciences stock is owned by insiders. Learn more on WLLW's insider holdings. Which Willow Biosciences insiders have been buying company stock? The following insiders have purchased WLLW shares in the last 24 months: Christopher Kenneth Savile (C$3,750.00), and Travis Doupe (C$4,207.50). How much insider buying is happening at Willow Biosciences? Insiders have purchased a total of 99,500 WLLW shares in the last 24 months for a total of C$7,957.50 bought. Willow Biosciences Key ExecutivesDr. Chris SavilePresident, Director & CEOMr. Travis Doupe (Age 52)Chief Financial Officer Compensation: $378.12k1 recent tradesDr. Trish ChoudharySenior Vice President of Research & DevelopmentMr. Troy T. TalkkariVice President of Corporate DevelopmentMr. Sanjib Singh Gill L.L.B. (Age 48)Corporate Secretary More Insider Trading Tools from MarketBeat Related Companies DB Insider Trades NDVA Insider Trades ENTG Insider Trades AQS Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (TSE:WLLW) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Willow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.